Spinal morphine/clonidine antinociceptive synergism is regulated by protein kinase C, but not protein kinase a activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 937-943

  Wei, Zhong You ^a   Roerig, Sandra C ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CLONIDINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MORPHINE; NARCOTIC ANALGESIC AGENT; PROTEIN KINASE C; ALPHA 2 ADRENERGIC RECEPTOR; CALPHOSTIN C; CHELERYTHRINE; PHORBOL DIBUTYRATE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG POTENTIATION; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRASPINAL DRUG ADMINISTRATION; MALE; MOUSE; PHYSIOLOGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TAIL FLICK TEST;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; CLONIDINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG SYNERGISM; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; MORPHINE; PROTEIN KINASE C;

EID: 0032240351     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Appleyard SM, Patterson TA, Jin W and Chavkin C (1997) Agonist-induced phosphorylation of the K-opioid receptor. J Neurochem 69: 2405-2412.
2. Arvidsson U, Riedl M, Chakrabarti M, Lee H-H, Nakano AH, Dado RJ, Loh HH, Law P-Y, Wessendorf MW and Eide R (1995) Distribution and targeting of a -opioid receptor (MORD in brain and spinal cord. J Neurosci 15:3328-3341.
3. Attali B, Nah S-Y and Vogel Z (1991) Phorbol ester pretreatment desensitized the inhibition of Ca + + channels induced by K-opiate, a2-adrenergic and muscarinic receptor agonists. J Neurochem 57: 1803-1806
4. Bernstein MA and Welch SP (1997) Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice. Drug Alcoh Depend 44: 41-46.
5. Bilsky EJ, Bernstein RN, Wang Z, Sadee W and Porreca F (1996) Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibi-tors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J Pharmacol Exp Ther 277: 484-490.
6. Busquets X, Escriba PV, Sastre M and Garcia-Sevilla JA (1995) Loss of protein kinase C-aβ in brain of heroin addicts and morphine-dependent rats. J Neurochem 64: 247-252.
7. Cai Y, Zhang Y, Wu Y and Pei G (1996) ôOpioid receptor in neuronal cells undergoes acute and homologous desensitization. Biochem Biophys Res Commun 219: 342347.
8. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T and Hidaka H (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMPdependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Bio! Chem 265: 5267-5272.
9. Cotecchia S, Kobilka BK, Daniel KW, Nolan RD, Lapetina EY, Caron MG, Lefkowitz RJ and Regan JW (1990) Multiple second messenger pathways of a-adrenergic receptor subtypes expressed in eukaryotic cells. J Biol Chem 265: 763-69.
10. De Kock MF, Pichon G and Scholtes J-L (1992) Intraoperative clonidine enhances postoperative morphine patient-controlled analgesia. Can J Anesth 39: 537-544.
11. Fundytus ME and Coderre TJ ( 1996) Chronic inhibition of intracellular Ca2+ release or protein kinase C activation significantly reduces the development of morphine dependence. E u. r J Pharmacol 300: 173-181.
12. Herbert JM, Augereau JM, Gleye J and Maffand JP (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C Biochem Biophys Res Commun 172: 993-999.
13. Hidaka H and Kobayashi R < 1992) Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicot 32: 377-397.
14. Hylden JLK and Wilcox GL (1980) Intrathecal morphine in mice: A new technique. Eur J Pharmacol 67: 313-316.
15. Hylden JLK and Wilcox GL (1983) Pharmacological characterization of substance P-induced nociception in mice: Modulation by opioid and noradrenergic agonists at the spinal level J Pharmacol Exp Ther 226: 398-404.
16. Kovoor A, Henry DJ and Chavkin C (1995) Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1) J Biol Chem 270: 589-595.
17. Law PY and Loh HH (19921 Second messengers in the transduction of multiple opioid receptors' signals, in Physiology at Drug Abuse. pp39-68, CRC Press, Boca Raton, FL.
18. Louie AK, Bass ES, Zhan J, Law PY and Loh HH (1990) Attenuation of opioid receptor activity by phorbol esters in neuroblastoma x glioma NG108-15 hybrid cells. J Pharmacol Exp Ther 253: 401-407.
19. Mao J, Price DD, Phillips LL, Lu J and Mayer DJ (1995) Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res 677: 257-267
20. Mayer DJ, Mao J and Price DD (1995) The development of morphine tolerance and dependence is associated with translocation of protein kinase C Pain 61: 365-374.
21. Meert TF and De Kock M (1994) Potentiation of the analgesic properties of fentanyllike opioids with a2-adrenoceptor agonists in rats. Anesthesiology 81: 677-688.
22. Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian M, Liu J, Schulman H and Yu L (1995) The human opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C J Neurosci 15: 2396-2406.
23. Narita M, Makimura M, Feng Y, Hoskins B and Ho IK (1994) Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res 650: 175-179.
24. Narita M, Mizoguchi H, Kampine JP and Tseng LF (1996) Role of protein kinase C in desensitization of spinal A-opioid-mediated antinociception in the mouse Br J Pharm 118: 1829-1835.
25. Narita M, Narita M, Mizoguchi H and Tseng LF (1995) Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered i-opioid receptor agonist in the mouse. Eur J Pharmacol 280:R1-R3.
26. Narita M, Ohsawa M, Mizoguchi H, Kamei J and Tseng LF (1997) Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by ju-but not e-opioid receptor agonist in the mouse. Neuroscience 76: 291-298.
27. Nestler EJ and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278: 58-63.
28. Nicholas AP, Hokfelt T and Pieribone VA (1996) The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol 17: 245-255.
29. Nicholson D, Reid A and Sawynok J (1991) Effects of forskolin and phosphodiesterase inhibitors on spinal antinociception by morphine. Pharm Biochem Behav 38: 753-758.
30. Omote K, Sonoda H, Kawamata M, Iwasaki H and Namiki A (1993) Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord. Anesthesiology 79: 746-752.
31. Park J, Forrest J, Kolesar R, Bhola D, Beattie S and Chu C (1996) Oral clonidine reduces postoperative PCA morphine requirements. Can J Anaesth 43: 990-996.
32. Pei G, Kieffer BL, Lefkowitz RJ and Freedman NJ (1995) Agonist-dependent phosphorylation of the mouse o-opioid receptor: Involvement of G protein-coupled receptor kinases but not protein kinase C Mol Pharmacol 48: 173-177.
33. Roerig SC ( 1995) Decreased spinal morphine/clonidine antinociceptive synergism in morphine-tolerant mice. Life Sei 56: PLI 15-122.
34. Roerig SC and Howse KM (1996) w-Agatoxin prevents spinal morphine/clonidine antinociceptive synergism Eur J Pharmacol 314: 293-300.
35. Ruffolo RR, Nichols AJ, Stadel J and Hieble JP (1991) Structure and function of a-adrenoceptors Pharmacol Rev 43: 475-505.
36. Smart D and Lambert DG (1996) The stimulatory effects of opioids and their possible role in the development of tolerance TIPS 17: 264-269.
37. Tallarida RJ and Murray RB (1987) Manual of Pharmacologie Calculations, Procedure 8, Graded Dose-Response, pp 26-31, Springer-Verlag, New York, NY.
38. Tallarida RJ, Porreca F and Cowen A (1989) Statistical analysis of drug-drug and site-site interactions with isobolograms Life Sei 45: 947-961.
39. Ueda H, Miyamae T, Hayashi C, Watanabe S, Fukushima N, Sasaki Y, Iwamura T and Misu Y (1995) Protein kinase C involvement in homologous desensitization of S-opioid receptor coupled to Glrphospholipase C activation in Xenopus oocytes. J Neurosci 15: 7485-7499.
40. Uhlen S, Persson ML, Alari L, Post C, Axelsson KL and Wikberg JES (1990) Antinociceptive actions of a2-adrenoceptor agonists in the rat spinal cord: evidence for antinociceptive a2-adrenoceptor subtypes and dissociation of antinociceptive tt2-adrenoceptors from cyclic AMP. J Neurochem 55: 1905-1914.
41. Wei ZY, Karim F and Roerig SC (19961 Spinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels. J Pharmacol Exp Ther 278: 1392-1407.
42. Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR and Wang JB (1996) Differential u opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 271: 11449-11454.
43. Zhang LJ, Wang XJ and Han JS ( 1990) Phorbol ester suppression of opioid analgesia in rats. Life Sa 47: 1775-1782.